<?xml version='1.0' encoding='utf-8'?>
<document id="18954985"><sentence text="Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors."><entity charOffset="6-36" id="DDI-PubMed.18954985.s1.e0" text="3,3-disubstituted pyrrolidines" /><entity charOffset="57-66" id="DDI-PubMed.18954985.s1.e1" text="serotonin" /><entity charOffset="67-81" id="DDI-PubMed.18954985.s1.e2" text="norepinephrine" /><entity charOffset="82-90" id="DDI-PubMed.18954985.s1.e3" text="dopamine" /><pair ddi="false" e1="DDI-PubMed.18954985.s1.e0" e2="DDI-PubMed.18954985.s1.e0" /><pair ddi="false" e1="DDI-PubMed.18954985.s1.e0" e2="DDI-PubMed.18954985.s1.e1" /><pair ddi="false" e1="DDI-PubMed.18954985.s1.e0" e2="DDI-PubMed.18954985.s1.e2" /><pair ddi="false" e1="DDI-PubMed.18954985.s1.e0" e2="DDI-PubMed.18954985.s1.e3" /><pair ddi="false" e1="DDI-PubMed.18954985.s1.e1" e2="DDI-PubMed.18954985.s1.e1" /><pair ddi="false" e1="DDI-PubMed.18954985.s1.e1" e2="DDI-PubMed.18954985.s1.e2" /><pair ddi="false" e1="DDI-PubMed.18954985.s1.e1" e2="DDI-PubMed.18954985.s1.e3" /><pair ddi="false" e1="DDI-PubMed.18954985.s1.e2" e2="DDI-PubMed.18954985.s1.e2" /><pair ddi="false" e1="DDI-PubMed.18954985.s1.e2" e2="DDI-PubMed.18954985.s1.e3" /></sentence><sentence text="A series of 3,3-disubstituted pyrrolidine monoamine triple reuptake inhibitors were discovered"><entity charOffset="12-51" id="DDI-PubMed.18954985.s2.e0" text="3,3-disubstituted pyrrolidine monoamine" /></sentence><sentence text=" Analogues with low nanomolar potency, good human in vitro microsomal stability and in vitro permeability, and low drug-drug interaction potential are described" /><sentence text=" One example showed in vivo anti-depressant-like effects in the mouse tail suspension assay with a minimum effective dose of 30 mg/kg i" /><sentence text="p" /><sentence text="" /></document>